Search results


Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data
You searched for:
Results: 46
1

Neonatology

NEONATOLOGY Normally, delivery takes place between the 37th and the 42nd week of gestation. By that time, the foetus is fully formed and developed enough to be able to adapt to extra-uterine life. However, in some cases delivery may occur before the 37th week of gestation. In that case, the...
2

Transplantology

Transplantology – transplantation of organs.   Transplantation of an organ, such as a kidney or a liver, is a life-saving modern treatment of patients whose organs do not function properly for some reason. The effectiveness and safety of organ transplantation is well...
3

Rare diseases

The term rare applies to those diseases affecting a limited number of people with a prevalence below a given cut-off point, which is codified by the legislation of each individual country. The EU sets this threshold at 0.05% of the population, i.e. one case for every 2,000 inhabitants (in the US a...
4

Respiratory

Chiesi Farmaceutici is fully committed to the care and improvement of the quality of life of people suffering from respiratory diseases including asthma and COPD (Chronic Obstructive Pulmonary Disease). Asthma and COPD are characterised by a reduction in the respiratory flow although they are...
5

Adverse reactions

Report adverse drug reaction Adverse drug reaction is any adverse and unintended effect resulting from a medication.   If you want to report an adverse reaction which occurred when using Chiesi Group drugs, please: print the Adverse Drug Reaction Reporting Form, fill in the minimum...
6

About us

Chiesi Group, one of the world’s leading producers of modern and innovative medical solutions, focuses on several therapeutic areas, including primarily respiratory diseases specialising in the treatment of asthma, cardiovascular diseases, neonatology, musculoskeletal disorders,...
7

History

-
8

Mission and Values

Our aim is to be recognised as a research-focused international Group, able to develop and commercialise innovative pharmaceutical solutions to improve the quality of human life. We wish to maintain a high quality entrepreneurial team characterised by self-confidence and a collaborative...
9

Management

-
10

Annual report

-
11

Research and Development

 Innovation is the driving force behind every technologically advanced industry, but for the pharmaceutical industry it plays a vital role since it concerns the health and quality of life of people. For Chiesi, Research and Development are a true human and technological asset and, together...
12

Therapeutic areas

-
13

Products

-
14

Business responsibility

As a member of the Employers’ Association of Innovative Pharmaceutical Companies INFARMA, CHIESI POLAND is a signatory of:   Code of Good Manufacturing Practice for Pharmaceutical Industry, which sets standards for activities in: promotion and advertisement of medicinal...
15

Ethics

In order to contribute to common good, ethical behaviour is a fundamental part of CHIESI POLAND’s business activity and expression of its responsibility towards the partners it works with, as well as people who make up the company. Every day, all employees are guided in their actions by...
16

Transparency

Code of Transparency   Cooperation between medical professionals and healthcare organizations has been a driving force in patient care and the development of innovative medicine for many years. Medical professionals and the affiliated organizations provide the pharmaceutical industry...
17

Chiesi Foundation

Founded in 2005, the Chiesi Foundation Onlus is a no-profit organisation which seeks to capitalise on Chiesi’s legacy of knowledge in order to promote health and alleviate the suffering of patients affected by chronic obstructive respiratory diseases, rare diseases and neonatal diseases. The...
18

Patient organizations support

  By providing patients with modern solutions out of concern for their health, Chiesi Group also supports local activities for education and preventive healthcare carried out by patient organizations and other healthcare stakeholders. Cooperation with patient organizations implies total...
19

Sitemap

-
20

Career

JOB OFFERS:   Information about current recruitment processes are published on the: www.pracuj.pl job advertising service   CAREER at Chiesi:   Development opportunities in Chiesi Poland: We support professional development and individual skills of employees by...
21

Cookies

For your convenience, the and www.chiesi.pl webpage, hereinafter referred to as the website, uses cookies and similar technologies, in order to adapt the website to user needs, and for statistical purposes. Cookies are small text files sent by the website visited by the Internet user to their...
22

Office

Chiesi Poland Sp. z o.o. Aleje Jerozolimskie 134 02-305 Warszawa, Polska TEL: +48 22 620 14 21 FAX: +48 22 652 37 79 VAT: 527-24-56-136 Trade Register No: 0000223692 Share Capital: 5.000.000 zl Court Designation: Regional Court for the City of Warsaw in Warsaw, XII Business Department of...
23

News

-
24

Search result

-
25

Term of use

-
26

Registration

-
27

Complaints

-
28

September 12 WE ACT DAY! - We Actively Care for Tomorrow

We do not need to be convinced how important it is to ensure favorable living conditions for the present and future generations and to implement the right to use environmental resources and preserve its value. We hear in the media about the importance of an ecological approach, about non-invasive...
29

CORPORATE SOCIAL RESPONSIBILITY: COMMUNITY DAY CENTER OF THE CHILDREN'S FRIENDS SOCIETY, UL. GROCHOWSKA 259A IN WARSAW - 10 AUGUST 2018

This year, we have been involved in the voluntary work of Chiesi Poland for the third time. Our activities are in line with the extensive charity work of the entire Chiesi Group. Let me remind you that our MISSION is to implement among Chiesi Poland employees the idea of sharing their time and...
30

REDUCTION OF CARBON DIOXIDE EMISSION

Chiesi Poland Sp. z o.o. as a socially responsible company and in accordance with the policy of sustainable development, pay special attention to care for the environment. As a part of the Chiesi Group, we responded to the global challenge and reduce carbon dioxide emissions.  Knowing that...
31

THE FIRST CHIESI SMILE CONFERENCE

On 9th June 2018 the THE FIRST CHIESI SMILE CONFERENCE was held in Warsaw. There was a lot of fun, joy and laughter – the perfect mix! On Saturday we’ve come to our office accompanied by a quite impressive delegation of young generation. Attractions and surprises were waiting for us...
32

ECOLOGY

Eurocentrum Office Complex is a green, user-friendly and eco-friendly building, which obtained American LEED CS precertification on the highest PLATINIUM level. (The Leadership in Energy & Environmental Design).   Obtaining such certificate requires substantial involvement during both...
33

Paolo Chiesi appointed honorary doctor at Karolinska Institute

Paolo Chiesi appointed honorary doctor at Karolinska Institute  Paolo Chiesi receives the award for his long-standing commitment to vital treatment of the lungs of premature babies. The ceremony will take place on 10 May in Stockholm City Hall    Stockholm May 10,...
34

Chiesi Group is the first global pharmaceutical company to become a certified B Corporation

Certified B Corporations meet the highest standards of verified social and environmental performance, transparency and accountability. Chiesi Group receives the B Corp certification from B Lab, a leading global sustainability non-profit body, in recognition of its corporate sustainability...
35

First Charity Chiesi Poland Run - EKIDEN 2019

-
36

Bramitob®

300 mg /4 ml, nebulizer solution     Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's consultation to which the final decision on the manner and scope of treatment is...
37

Budiair®

200 micrograms /metered dose, inhalation aerosol, solution     Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's consultation to which the final decision on the manner and...
38

Budiair® (Jet)

200 micrograms / metered dose, inhalation aerosol, solutionpackage with Jet inhalation chamber     Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's consultation to which...
39

Curosurf®

80 mg /ml, suspension for intratracheal and bronchoalveolar administrationFraction of phospholipids from the lungs of the pig       Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not...
40

Envarsus®

Envarsus 0.75 mg prolonged-release tabletsEnvarsus 1 mg prolonged-release tabletsEnvarsus 4 mg prolonged-release tablets     Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a...
41

Flamexin®

20 mg, tablets   Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's consultation to which the final decision on the manner and scope of treatment is appropriate.
42

Fostex®

(100 micrograms + 6 micrograms)/dose, inhalation spray, solutionThe drug is intended for use in adults.   Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's consultation to which...
43

Holoclar®

79,000 - 316,000 cells / cm2, live replacement tissue     Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's consultation to which the final decision on the manner and...
44

Peyona®

20 mg/ml, solution for infusion and oral solution      Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's consultation to which the final decision on the manner and...
45

Atimos®

12 micrograms / metered dose, inhalation aerosol, solution  Therapeutic area: Respiratory    Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's consultation to which...
46

Trimbow®

87 micrograms + 5 micrograms + 9 micrograms, inhalation spray, solution   Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's consultation to which the final decision on the...